BPBayron David García Pasichana

Bayron David García Pasichana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bayron David García Pasichana has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Remote intracerebral hemorrhage after cranioplasty: A rare and contralateral complication defying surgical expectations. Case report

    by Bayron David García-Pasichaná, Mateo Aguirre-Flórez, Daniel Toro-Restrepo, Ernesto Ricaurte-Arcos, María de Los Ángeles García-Pasichaná, Valeria López-Pulgarín, Daniel Millán-Morales

    Background: Remote intracerebral hemorrhage (RIH) is a rare but potentially serious postoperative complication, most often reported after spinal or supratentorial neurosurgical procedures. While typically observed in the cerebellum, RIH may occur in supratentorial regions or both compartments. Its multifactorial pathophysiology involves cerebrospinal fluid loss, venous injury and impaired autoregulation. Case report: We describe a 58-year-old male with hypertension who developed a left frontal hematoma requiring decompressive craniectomy and ventriculoperitoneal shunt placement. One year later, after elective cranioplasty, he suffered acute neurological deterioration. Imaging revealed a right temporo-occipital and cerebellar hemorrhage, remote from the surgical site. Airway protection required tracheostomy and gastrostomy. Serial imaging showed gradual improvement. Conclusions: This case underscores that cranioplasty, although considered low risk, can trigger remote intracerebral hemorrhage. Early recognition and strict neuromonitoring are crucial for optimal outcomes. MeSH keywords: Neurosurgical procedures, postoperative complications, postoperative hemorrhage, intracerebral hemorrhage

  • Open Access

    Unraveling the neurological enigma: central diabetes insipidus and extrapontine osmotic demyelination caused by covid-19 case report

    by Mateo Aguirre-Flórez, Laura Alejandra Jímenez-Osorio, Bayron David García-Pasichana, Harold Sebastián Castillo-Pastuzan, Juan José Gutiérrez-Patermina

    Background: COVID-19 infection produces various symptoms and affects multiple systems, including the endocrine system. Lesions have been documented at the hypothalamic and pituitary axis, hypothetically explained by the presence of angiotensin II receptors in these structures and by direct immune-mediated viral lesions. These manifest with electrolyte and hormonal alterations. Case report: We present the case of a female patient who, after infection by SARS-CoV-2, presented with hypernatremia refractory to conventional management. Her diagnostic study documented hyposthenuria, high serum osmolarity, and low urinary osmolarity. The condition was corrected with desmopressin, leading to a diagnosis of central diabetes insipidus. A brain MRI revealed a lesion in the pituitary gland, confirming the clinical findings. The only etiological hypothesis for this lesion is its association with SARS-CoV-2 infection. Conclusions: Understanding the complications secondary to COVID-19 infection in the endocrine setting is essential for early diagnosis and targeted treatment. This knowledge can significantly improve the quality of life for patients affected by such complications.

  • Open Access

    Toxicological diagnosis in the critical patient: The challenge

    by Diana Ávila Reyes, Bayron David García Pasichana, Juan Camilo Galvis Mejía, José Fernando Gómez González, Marisol Margarita Villadiego Molinares, Mateo Aguirre Flórez, Yessica Alejandra González Cuéllar

    Introduction: A high percentage of patients who survived poisoning will be transferred to the Intensive Care Unit (ICU) to continue their management in relation to the severity of the poisoning, and possible complications that arise in this scenario. The clinical results will depend on several factors, such as the ingested dose, the characteristics of the substance, the time of medical attention, and the pre-existing state of health of the patient. Objective: To review the clinical behavior of poisonings in the critically ill patient. Recent findings: The data bases that yielded relevant bibliographical results were Web of Sciences, Scopus, PubMed, SciELO, and bibliographic references published between 2012 and 2020 were chosen. Conclusions: The clinical behavior of poisonings in the critically ill patient is atypical. The intensivist must have an in-depth knowledge of the behavior and pathophysiology of the toxins since making a medical diagnosis on the stage of the critically ill patient is challenging. The integration of all possible medical tools is required to achieve this in the absence of clinical history, and the implementation of early management strategies is necessary to reach physiological restoration by using a continuous evaluation approach. The severity of poisoning in the critically ill patient demands interdisciplinary management that includes assessment by Clinical Toxicology.


  • Open Access

    Mechanical ventilation in SARS-CoV-2 patients: state of art

    by Diana Ávila Reyes, Bayron David García P., Guillermo Salazar Gutierrez, José Fernando Gómez González, David Ricardo Echeverry Piedrahita, Juan Camilo Galvis, Mateo Aguirre-Flórez

    COVID-19-associated infection leads to a pathology of yet unknown clinical behavior, confronting the clinician with various challenges. An extensive search was conducted based on review articles on SARS-CoV-2 infection and studies including mechanical ventilation management strategies in order to complete this narrative review. Evidenced-based treatment for SARS-CoV2 infection is still in the works. We have some tools from our knowledge from past experiences indicating that a step-wise management approach should be used, without neglecting other joint therapeutic measures for improved clinical outcomes of a condition with a high mortality. The current recommendations indicate that patients with severe acute respiratory failure due to SARS-CoV-2 should be managed with protective mechanical ventilation measures. No strong evidence is yet available on the individualization of mechanical ventilation therapy according to phenotypes.